Ascentage Pharma Group International (HKG:6855)

HKG:6855 Statistics

Total Valuation

HKG:6855 has a market cap or net worth of HKD 15.74 billion. The enterprise value is 15.20 billion.

Market Cap	15.74B
Enterprise Value	15.20B

Important Dates

The last earnings date was Wednesday, March 25, 2026.

Earnings Date	Mar 25, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:6855 has 368.05 million shares outstanding. The number of shares has increased by 17.89% in one year.

Current Share Class	368.05M
Shares Outstanding	368.05M
Shares Change (YoY)	+17.89%
Shares Change (QoQ)	+9.35%
Owned by Insiders (%)	12.95%
Owned by Institutions (%)	18.65%
Float	281.98M

Valuation Ratios

PE Ratio	n/a
Forward PE	34.74
PS Ratio	24.63
PB Ratio	10.60
P/TBV Ratio	11.46
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-10.99
EV / Sales	23.80
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.79, with a Debt / Equity ratio of 1.48.

Current Ratio	1.79
Quick Ratio	1.66
Debt / Equity	1.48
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-22.42

Financial Efficiency

Return on equity (ROE) is -154.56% and return on invested capital (ROIC) is -28.83%.

Return on Equity (ROE)	-154.56%
Return on Assets (ROA)	-23.02%
Return on Invested Capital (ROIC)	-28.83%
Return on Capital Employed (ROCE)	-52.24%
Weighted Average Cost of Capital (WACC)	8.19%
Revenue Per Employee	1.06M
Profits Per Employee	-2.29M
Employee Count	605
Asset Turnover	0.17
Inventory Turnover	2.78

Taxes

In the past 12 months, HKG:6855 has paid 7.72 million in taxes.

Income Tax	7.72M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +24.89% in the last 52 weeks. The beta is 0.87, so HKG:6855's price volatility has been lower than the market average.

Beta (5Y)	0.87
52-Week Price Change	+24.89%
50-Day Moving Average	47.12
200-Day Moving Average	64.74
Relative Strength Index (RSI)	50.87
Average Volume (20 Days)	2,289,679

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:6855 had revenue of HKD 638.89 million and -1.38 billion in losses. Loss per share was -3.88.

Revenue	638.89M
Gross Profit	584.43M
Operating Income	-1.35B
Pretax Income	-1.38B
Net Income	-1.38B
EBITDA	-1.26B
EBIT	-1.35B
Loss Per Share	-3.88

Balance Sheet

The company has 2.75 billion in cash and 2.20 billion in debt, with a net cash position of 545.68 million or 1.48 per share.

Cash & Cash Equivalents	2.75B
Total Debt	2.20B
Net Cash	545.68M
Net Cash Per Share	1.48
Equity (Book Value)	1.48B
Book Value Per Share	3.98
Working Capital	1.45B

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	90.56M
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 91.48%, with operating and profit margins of -211.14% and -216.47%.

Gross Margin	91.48%
Operating Margin	-211.14%
Pretax Margin	-215.29%
Profit Margin	-216.47%
EBITDA Margin	-197.22%
EBIT Margin	-211.14%
FCF Margin	n/a

Dividends & Yields

HKG:6855 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-17.89%
Shareholder Yield	-17.89%
Earnings Yield	-8.79%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4